These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9562247)

  • 1. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone.
    Tyagi SC; Smiley LM; Mujumdar VS; Clonts B; Parker JL
    Mol Cell Biochem; 1998 Apr; 181(1-2):107-16. PubMed ID: 9562247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells.
    Tyagi SC
    Am J Physiol; 1998 Feb; 274(2):C396-405. PubMed ID: 9486129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix.
    Tyagi SC
    Clin Exp Hypertens; 1999 Apr; 21(3):181-98. PubMed ID: 10225475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells.
    Mujumdar VS; Hayden MR; Tyagi SC
    J Cell Physiol; 2000 Apr; 183(1):28-36. PubMed ID: 10699963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
    Kang SS; Wong PW; Cook HY; Norusis M; Messer JV
    J Clin Invest; 1986 May; 77(5):1482-6. PubMed ID: 3700650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM; DeFrang RD; Harris EJ; Porter JM
    J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
    Spence JD
    Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells.
    Heydrick SJ; Weiss N; Thomas SR; Cap AP; Pimentel DR; Loscalzo J; Keaney JF
    Free Radic Biol Med; 2004 Mar; 36(5):632-40. PubMed ID: 14980706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of homocyst(e)ine in the prediction of arteriosclerosis.
    Fortin LJ; Genest J
    Clin Biochem; 1995 Apr; 28(2):155-62. PubMed ID: 7628074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cyst(e)ine in homocyst(e)inemia.
    Malloy MH; Rassin DK; Gaull GE
    Am J Clin Nutr; 1981 Dec; 34(12):2619-21. PubMed ID: 7315764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
    J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism.
    Graeber JE; Slott JH; Ulane RE; Schulman JD; Stuart MJ
    Pediatr Res; 1982 Jun; 16(6):490-3. PubMed ID: 6808450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocyst(e)ine impairs endocardial endothelial function.
    Tyagi SC; Smiley LM; Mujumdar VS
    Can J Physiol Pharmacol; 1999 Dec; 77(12):950-7. PubMed ID: 10606441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics.
    Kang SS; Wong PW; Curley K
    Pediatr Res; 1982 May; 16(5):370-2. PubMed ID: 7099755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation.
    Sengupta S; Wehbe C; Majors AK; Ketterer ME; DiBello PM; Jacobsen DW
    J Biol Chem; 2001 Dec; 276(50):46896-904. PubMed ID: 11592966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.
    Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Libby P
    Ann N Y Acad Sci; 1995 Jan; 748():501-7. PubMed ID: 7695193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.